Turka Laurence A.

Chief Scientific Officer at Rubius Therapeutics, Inc.

Sold, on record
$17k
Dollars the filings state
Form 4 sales
2
Latest Jan 31, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Jan 31, 2023Plan not stated

    Rubius Therapeutics, Inc.

    Sold 12.4% of their holdings

    $6222,593 shares at $0.24

    Filed Jan 31, 2023Form 4

  2. Feb 1, 2022Unusual

    Rubius Therapeutics, Inc.

    Sold 33.8% of their holdings

    $17k2,517 shares at $6.57

    Filed Feb 1, 2022Form 4

2 of 2

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Turka Laurence A.
Source
Jan 31, 2023Jan 31, 2023Rubius Therapeutics, Inc.Chief Scientific OfficerForm 4 sale2,593$62212.4%Plan not statedSEC
Feb 1, 2022Feb 1, 2022Rubius Therapeutics, Inc.Chief Scientific OfficerForm 4 sale2,517$17k33.8%UnusualSEC